Normocarb HF is the first solution approved for direct infusion into a CRRT circuit
Patients receiving hemofiltration require a solution that is simple, effective, and safe. Caregivers need to have absolute confidence in the product and its ability to work in any manner of administration.
Normocarb HF is a pharmaceutical-grade, clinically-tested, FDA approved, protocol-neutral hemofiltration solution for CRRT.
Normocarb HF is now widely available with bicarbonate concentrations of 25 mmol/L and 35 mmol/L. Normocarb HF is a hemofiltration or replacement solution for direct infusion into a CRRT circuit.
For patients receiving CRRT, the patient care solution is Normocarb HF.
FOR INTENSIVISTS
A safe and versatile solution that provides metabolic electrolyte control – regardless of protocol.
FOR PHARMACISTS
A practical and pharmaceutical-grade solution that reduces handling and eliminates the risk of error.
FOR NURSES
A simple and reliable solution that facilitates workflow and allows staff to focus on patient care.
FOR NEPHROLOGISTS
A lactate-free, protocol-neutral solution that maintains benefit over the long-term while limiting the risk of metabolic disturbances.